IDV vehicle

75A50122D00004

THE PURPOSE OF THIS REQUIREMENT IS TO 1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO A HHS DESIGNATED PUBLIC HEALTH EMERGENCY. 2) PRODUCE VACCINES AG

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeBARDA - ASPR / DAAPPO / BARDA DCMA
NAICS325414 — Biological Product (except Diagnostic) Manufacturing
PSC6505 — Drugs and Biologicals
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$0
Current contract valueNot reported
Potential contract value / ceiling$13.4B
Start dateFeb 22, 2022
Current end dateNot available
Potential end dateNot available
Latest award activityMar 24, 2026
Source loadedSep 19, 2026

Funding and modification history

Showing the latest 7 of 7 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Mar 24, 2026P00014$0(1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE VACCINES AGAINST INFLUENZA VIRUS, AND INFLUENZA
Dec 12, 2025P00013$0(1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE VACCINES AGAINST INFLUENZA VIRUS, AND INFLUENZA
Nov 20, 2025P00012$0(1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE VACCINES AGAINST INFLUENZA VIRUS, AND INFLUENZA
Oct 14, 2025P00011$0(1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE VACCINES AGAINST INFLUENZA VIRUS, AND INFLUENZA
Jun 12, 2025P00010$0(1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE VACCINES AGAINST INFLUENZA VIRUS, AND INFLUENZA
May 8, 2025P00009$0(1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE VACCINES AGAINST INFLUENZA VIRUS, AND INFLUENZA
Jan 21, 2025P00008$0(1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE VACCINES AGAINST INFLUENZA VIRUS, AND INFLUENZA

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Wendell ConyersContactwendell.conyers@hhs.gov
202-308-9247
SourceSep 10, 2021
Deitra WilliamsContactdeitra.williams@hhs.gov
202-845-4483
SourceSep 10, 2021
Wendell ConyersContactwendell.conyers@hhs.gov
202-308-9247
SourceSep 3, 2021
Deitra WilliamsContactdeitra.williams@hhs.gov
202-845-4483
SourceSep 3, 2021
Wendell ConyersContactwendell.conyers@hhs.gov
202-308-9247
SourceAug 29, 2021
Deitra WilliamsContactdeitra.williams@hhs.gov
202-845-4483
SourceAug 29, 2021
Wendell ConyersContactwendell.conyers@hhs.gov
202-308-9247
SourceAug 26, 2021
Deitra WilliamsContactdeitra.williams@hhs.gov
202-845-4483
SourceAug 26, 2021
Wendell ConyersContactwendell.conyers@hhs.gov
202-308-9247
SourceAug 25, 2021
Deitra WilliamsContactdeitra.williams@hhs.gov
202-845-4483
SourceAug 25, 2021
Wendell ConyersContactwendell.conyers@hhs.gov
202-308-9247
SourceAug 18, 2021
Deitra WilliamsContactdeitra.williams@hhs.gov
202-845-4483
SourceAug 18, 2021
Wendell ConyersContactwendell.conyers@hhs.gov
202-308-9247
SourceAug 17, 2021
Deitra WilliamsContactdeitra.williams@hhs.gov
202-845-4483
SourceAug 17, 2021
Wendell ConyersContactwendell.conyers@hhs.gov
202-308-9247
SourceAug 7, 2021
Deitra WilliamsContactdeitra.williams@hhs.gov
202-845-4483
SourceAug 7, 2021
Wendell ConyersContactwendell.conyers@hhs.gov
202-308-9247
SourceJul 26, 2021
Deitra WilliamsContactdeitra.williams@hhs.gov
202-845-4483
SourceJul 26, 2021
Wendell ConyersContactwendell.conyers@hhs.gov
202-308-9247
SourceJul 23, 2021
Deitra WilliamsContactdeitra.williams@hhs.gov
202-845-4483
SourceJul 23, 2021
Wendell ConyersContactwendell.conyers@hhs.gov
202-308-9247
SourceJun 29, 2021
Deitra WilliamsContactdeitra.williams@hhs.gov
202-845-4483
SourceJun 29, 2021

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.